Loading organizations...
Loading organizations...
Key people at ShangPharma Investment Group.
Key people at ShangPharma Investment Group.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2018 | Skyhawk Therapeutics | $40.0M Series A | — | Good Growth Capital, Andrew Bedford, Tim Disney, Agent Capital, Alexandria Venture Investments, GreatPoint Ventures |
| Jan 16, 2018 | APRINOIA Therapeutics | $11.1M Series B | Daiwa Corporate Investment, Kevin Kuk-Hyun Kyung | Taian Venture Capital |
| Dec 1, 2017 | Obsidian Therapeutics | $50.0M Series A | Blake Byers | Atlas Venture, F-Prime Capital Partners, Alexandria Venture Investments, Gladys Nunez, Karen Hong, Carolyn Ng |
| Jun 1, 2016 | Morphic Therapeutic | $52.0M Series A | SR One | Atlas Venture, Third Rock Ventures, Ysios Capital, AbbVie Ventures, Omega Funds, Polaris Partners, Ramy Farid, T.A. Springer |
